1 mai 2020 – Policy Brief

Risk factors for severe manifestations of SARS-CoV-2 infection

Download Policy Brief PDF


Cette Policy Brief n’a pas été traduite. Une mise à jour avec une synthèse en français a été publiée le 19 novembre (Evaluation des facteurs de risque du Covid-19).


The evaluation of the risk of hospital and ICU admission, as well as the mortality associated with the COVID-19 is an important tool to plan the necessary resources to manage and care for patients, and to evaluate the consequences of the disease. Knowing associated risk factors will enable better care for patients, including advice regarding specific drugs either associated or as important not associated with an increased risk for mortality. Despite a high number of infected patients around the world, and many published data, the quality of these publications is generally low, with a risk of bias and confounding factors. Even though this should therefore be interpreted with great caution, and regularly evaluated, older age and cardiovascular and pulmonary comorbidities are associated with a higher risk of severe disease.

Date of request: 19/4/2020
Date of response: 1/5/2020

In response to request from: NCS-TF Advisory Board

Comment on planned updates: This is a short systematic review by the group, based on the work of N. Müller (USZ) and T. Fumeaux (SGI) and the Clinical Care Group. The literature search was updated on 01.05.2020. Data are regularly published, with a progressive increase in the methodological quality and better reproducibility, this document will therefore be updated after 4 weeks, and thereafter when necessary.

Expert groups and individuals involved: Clinical Group

Contact persons: Nicolas Müller (Nicolas.Mueller@usz.ch) – Thierry Fumeaux (thierry.fumeaux@ghol.ch) – Manuel Battegay (Manuel.Battegay@usb.ch), Head of  Clinical Expert Group

La Swiss National COVID-19 Science Task Force ayant été dissoute au 31 mars 2022, plus aucune évaluation de la situation épidémiologique, mise à jour scientifique ou policy brief ne sera publiée à l’avenir. Toutes les publications, pages et informations antérieures de la Science Task Force restent disponibles sur ce site web.